187 results
8-K
EX-10.2
CELU
Celularity Inc - Ordinary Shares
15 Mar 24
Entry into a Material Definitive Agreement
5:01pm
District Court in the Governing Jurisdiction. The Company waives any right to object to the maintenance of any suit, claim, action, litigation … of the Governing Jurisdiction on the basis of improper venue or inconvenience of forum.
(iii) Any suit, claim, action, litigation or proceeding of any kind
8-K
EX-10.5
CELU
Celularity Inc - Ordinary Shares
15 Mar 24
Entry into a Material Definitive Agreement
5:01pm
District Court in the Governing Jurisdiction. The Company waives any right to object to the maintenance of any suit, claim, action, litigation … of the Governing Jurisdiction on the basis of improper venue or inconvenience of forum.
(iii) Any suit, claim, action, litigation or proceeding of any kind
8-K
EX-10.4
CELU
Celularity Inc - Ordinary Shares
15 Mar 24
Entry into a Material Definitive Agreement
5:01pm
, claim, action, litigation or proceeding of any kind or description, whether in law or equity, whether in contract or in tort or otherwise, in any … , litigation or proceeding of any kind or description, whether in law or equity, whether in contract or tort or otherwise, brought by the Company against
425
CELU
Celularity Inc - Ordinary Shares
21 Apr 21
Business combination disclosure
4:19pm
, “forward-looking statements” within the meaning of The Private Securities Litigation Reform Act of 1995. Forward-looking statements may include … ) Celularity’s business, expansion plans and opportunities; and (xx) the outcome of any known and unknown litigation and regulatory proceedings. These forward
425
CELU
Celularity Inc - Ordinary Shares
1 Jul 21
Business combination disclosure
5:09pm
of The Private Securities Litigation Reform Act of 1995, as well as within the meaning of Section 27A of the Securities Act of 1933, as amended … and opportunities; (xx) the outcome of any known and unknown litigation and regulatory proceedings; and (xxi) changes in applicable laws, ordinances
425
dntkjoh
1 Feb 21
Business combination disclosure
5:22pm
8-K
EX-99.1
t3fi14l
14 May 21
GX Acquisition Corp. Announces Shareholder Approval of Extension Proposal
5:09pm
425
wldpf1u5bsd5
20 Apr 21
Business combination disclosure
6:14am
DEFA14A
EX-99.1
aeco5y1khne0wt
10 May 21
Additional proxy soliciting materials
7:55am
8-K
EX-99.1
pdo1ibbxm
10 May 21
GX Acquisition Corp. Announces Additional Contributions to Trust Account
7:49am
425
EX-99.1
6q6sj6dvp3110huuxesq
14 May 21
Business combination disclosure
5:07pm
425
EX-99.1
7frymz
10 May 21
Business combination disclosure
7:47am
8-K
x56ylmudt4 77
18 Mar 21
Other Events
8:03am
425
xl0iay 4jednul3qi
18 Mar 21
Business combination disclosure
8:02am
8-K
EX-99.1
3yurtpgulk5v
1 Jul 21
Celularity and Arthrex Enter into Exclusive Supply and Distribution Agreement for Multiple Commercial Products
5:07pm
8-K
h9wja zli8h9nae37z
29 Jun 21
Regulation FD Disclosure
4:21pm
8-K
l2mgy6as otc9
5 May 21
Celularity Enters into Multi-Year Strategic Partnership with Palantir Technologies
4:32pm
425
cvqavd
5 May 21
Business combination disclosure
4:34pm
8-K
6vhdvyypqmwbs1
1 Jul 21
Celularity and Arthrex Enter into Exclusive Supply and Distribution Agreement for Multiple Commercial Products
5:07pm
425
d6lx72
13 Apr 21
Business combination disclosure
1:01pm